Literature DB >> 15190146

Erythropoietin for neurologic protection and diabetic neuropathy.

Stuart A Lipton1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15190146     DOI: 10.1056/NEJMcibr041121

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

Review 1.  Anemia and diabetic nephropathy.

Authors:  Eberhard Ritz
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 2.  Notes on the kidney and its diseases for the neurologist.

Authors:  Michael S Zandi; Alasdair J Coles
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05       Impact factor: 10.154

Review 3.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Authors:  Chung-Jung Chiu; Allen Taylor
Journal:  Prog Retin Eye Res       Date:  2010-09-22       Impact factor: 21.198

4.  Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2 Akita) diabetic mouse sympathetic ganglia.

Authors:  Robert E Schmidt; Dongyan Feng; Qiuling Wang; Karen G Green; Lisa L Snipes; Michael Yamin; Michael Brines
Journal:  Exp Neurol       Date:  2011-08-18       Impact factor: 5.330

5.  A pilot study of darbepoetin alfa for prophylactic neuroprotection in aortic surgery.

Authors:  Steven R Messé; Michael L McGarvey; Joseph E Bavaria; Alberto Pochettino; Wilson Y Szeto; Albert T Cheung; Elizabeth Leitner; Scott W Miller; Scott E Kasner
Journal:  Neurocrit Care       Date:  2013-02       Impact factor: 3.210

6.  Erythropoietin: a multimodal neuroprotective agent.

Authors:  Nadiya Byts; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

7.  Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice.

Authors:  Robert E Schmidt; Karen G Green; Dongyan Feng; Denise A Dorsey; Curtis A Parvin; Jin-Moo Lee; Qinlgi Xiao; Michael Brines
Journal:  Exp Neurol       Date:  2007-10-29       Impact factor: 5.330

8.  Erythropoietin and polyneuropathy in older persons.

Authors:  Fulvio Lauretani; Stefania Bandinelli; Elsa S Strotmeyer; Anna Maria Corsi; Angelo Di Iorio; Jack M Guralnik; Luigi Ferrucci
Journal:  Mech Ageing Dev       Date:  2008-03-10       Impact factor: 5.432

9.  The pharmacokinetic profile of recombinant human erythropoietin is unchanged in patients undergoing cardiac surgery.

Authors:  Stuart A McCluskey; Wing K Cheung; Rita Katznelson; Humara Poonawala; Ludwik Fedorko; George Djaiani; Bobby Mehta; Keyvan Karkouti
Journal:  Eur J Clin Pharmacol       Date:  2008-10-30       Impact factor: 2.953

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.